Literature DB >> 17548775

Attention and memory in the preclinical stage of dementia.

Maria Caterina Silveri1, Giada Reali, Carina Jenner, Maria Puopolo.   

Abstract

The aim of this study was to investigate whether attention may be specifically impaired in Alzheimer's disease from the early stages of the disease. Subgroups of patients with different types of mild cognitive impairment were selected according to standard criteria. Patients and controls were given tasks exploring various subcomponents of attention and executive functions. Only subgroups of mild cognitive impairment characterized by memory disorders obtained lower scores than controls on attention and executive tasks. On the basis of the scores obtained on the Clinical Dementia Rating at the 1-year follow-up, patients were redistributed into 2 groups: those who developed and those who did not develop dementia. Patients who presented evolution to dementia already had, at baseline, lower scores than patients who did not evolve on tasks exploring attention and executive functions. The results suggest that not only memory disorders but also attention/executive deficits may characterize dementia at the onset.

Entities:  

Mesh:

Year:  2007        PMID: 17548775     DOI: 10.1177/0891988706297469

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  17 in total

1.  Spousal interrelations in self-reports of cognition in the context of marital problems.

Authors:  William J Strawbridge; Margaret I Wallhagen; Sarah J Shema
Journal:  Gerontology       Date:  2010-07-08       Impact factor: 5.140

2.  A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.

Authors:  Adam E Green; Jeremy R Gray; Colin G Deyoung; Timothy R Mhyre; Robert Padilla; Amanda M Dibattista; G William Rebeck
Journal:  Neuropsychologia       Date:  2014-01-02       Impact factor: 3.139

3.  Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 project.

Authors:  Virginia Boccardi; Valentina Bubba; Ilenia Murasecco; Martina Pigliautile; Roberto Monastero; Roberta Cecchetti; Michela Scamosci; Patrizia Bastiani; Patrizia Mecocci
Journal:  Aging Clin Exp Res       Date:  2020-05-03       Impact factor: 3.636

4.  Aspects of Attention Predict Real-World Task Performance in Alzheimer's Disease.

Authors:  Beyon H Miloyan; Jill Razani; Andrea Larco; Justina Avila; Julia Chung
Journal:  Appl Neuropsychol Adult       Date:  2013-02-13       Impact factor: 2.248

5.  An examination of an enhancing effect of music on attentional abilities in older persons with mild cognitive impairment.

Authors:  Jessica I Lake; Felicia C Goldstein
Journal:  Percept Mot Skills       Date:  2011-02

6.  Association between circadian rhythms, sleep and cognitive impairment in healthy older adults: an actigraphic study.

Authors:  Andy Cochrane; Ian H Robertson; Andrew N Coogan
Journal:  J Neural Transm (Vienna)       Date:  2012-04-10       Impact factor: 3.575

7.  Therapeutic application of melatonin in mild cognitive impairment.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Analía M Furio; Luis I Brusco
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

8.  The MMSE orientation for time domain is a strong predictor of subsequent cognitive decline in the elderly.

Authors:  Elizabeth Guerrero-Berroa; Xiaodong Luo; James Schmeidler; Michael A Rapp; Karen Dahlman; Hillel T Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2009-12       Impact factor: 3.485

9.  The BDNF Val66Met polymorphism moderates the relationship between cognitive reserve and executive function.

Authors:  D D Ward; M J Summers; N L Saunders; K Ritchie; J J Summers; J C Vickers
Journal:  Transl Psychiatry       Date:  2015-06-30       Impact factor: 6.222

10.  Neural Correlates of Unsuccessful Memory Performance in MCI.

Authors:  N Chechko; E I Drexler; B Voss; T Kellermann; A Finkelmeyer; F Schneider; U Habel
Journal:  Front Aging Neurosci       Date:  2014-08-13       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.